Despite Pressure, Biogen’s Alzheimer’s Drug Still a Likely Blockbuster
[ad_1] American taxpayers are set to foot most of the bill for Biogen ’s new treatment for Alzheimer’s disease, and investors are nervous. The Food… Read More »Despite Pressure, Biogen’s Alzheimer’s Drug Still a Likely Blockbuster